Secreted phosphoprotein 1 promotes ovarian cancer metastasis by regulating the function of cancer-associated fibroblasts
Eurasian Journal of Medicine and Oncology · 20.05.2026 · 025010560
DOI: 10.36922/ejmo025010560 ↗Kurz gefasst
Fachartikel in der Zeitschrift Eurasian Journal of Medicine and Oncology, online erschienen am 20.05.2026. Verfasst von Xuerou Wang und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Ovarian cancer is a leading cause of cancer-related mortality among females, characterized by its aggressive behavior and metastatic potential. Secreted phosphoprotein 1 (SPP1) has been implicated in various malignancies; however, its specific role in ovarian cancer and its effects on cancer-associated fibroblasts (CAFs) remain poorly understood.
Objectives
To analyze the expression level of SPP1 in ovarian cancer and its correlation with patients’ prognostic survival, and to investigate the specific effects and potential molecular mechanisms of SPP1 on CAFs through transcriptome sequencing and in vitro and in vivo assays.
Methods
We assessed SPP1 expression in high-grade serous ovarian cancer (HGSOC) tissues and its correlation with patient prognosis using Kaplan–Meier survival analysis and immunohistochemistry. CAFs and normal fibroblasts were isolated for further analysis.
Results
Co-culture experiments using mouse ovarian cancer cells and mouse fibroblasts (NIH/3T3) demonstrated that SPP1 enhances CAF migration and invasion. RNA sequencing revealed that SPP1 promotes the secretion of multiple cytokines from CAFs, including interleukin-6 and C-X-C motif chemokine ligand 1. Western blot analysis demonstrated that SPP1 treatment activates the phosphoinositide 3-kinase/protein kinase B (PI3K/AKT) signaling pathway in CAFs. In vivo experiments using a mouse peritoneal metastasis model with co-cultured mouse ovarian cancer cells and mouse fibroblasts demonstrated that SPP1 knockdown significantly reduced ovarian cancer metastatic foci.
Conclusions
Our findings suggest that high SPP1 expression correlates with poor prognosis in patients with ovarian cancer and that SPP1 facilitates malignant progression by enhancing cytokine secretion in CAFs through the PI3K/AKT pathway, highlighting SPP1 as an attractive target for HGSOC therapy.
Zitieren
APA
Wang, X., Li, L., Li, J., Tan, W., Wang, X., Fu, W., Li, L., & Xie, Y. (2026). Secreted phosphoprotein 1 promotes ovarian cancer metastasis by regulating the function of cancer-associated fibroblasts. Eurasian Journal of Medicine and Oncology, 0(0), 025010560. https://doi.org/10.36922/ejmo025010560
Vancouver
Wang X, Li L, Li J, Tan W, Wang X, Fu W, et al. Secreted phosphoprotein 1 promotes ovarian cancer metastasis by regulating the function of cancer-associated fibroblasts. Eurasian Journal of Medicine and Oncology. 2026;0(0):025010560. doi:10.36922/ejmo025010560
BibTeX
@article{Wang2026,
author = {Wang, Xuerou and Li, Longyang and Li, Jinglin and Tan, Wencao and Wang, Xinyu and Fu, Wan and Li, Linlin and Xie, Ya},
title = {Secreted phosphoprotein 1 promotes ovarian cancer metastasis by regulating the function of cancer-associated fibroblasts},
journal = {Eurasian Journal of Medicine and Oncology},
year = {2026},
volume = {0},
number = {0},
pages = {025010560},
doi = {10.36922/ejmo025010560}
}
EUVIMED